Proof of Gene Doping in a Mouse Model with a Human Erythropoietin Gene Transferred Using an Adenoviral Vector.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
16 08 2021
Historique:
received: 23 06 2021
revised: 05 08 2021
accepted: 09 08 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 4 2 2022
Statut: epublish

Résumé

Despite the World Anti-Doping Agency (WADA) ban on gene doping in the context of advancements in gene therapy, the risk of

Identifiants

pubmed: 34440425
pii: genes12081249
doi: 10.3390/genes12081249
pmc: PMC8392868
pii:
doi:

Substances chimiques

EPO protein, human 0
Erythropoietin 11096-26-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Bioinformatics. 2019 Jun 1;35(11):1966-1967
pubmed: 30346488
Blood. 2011 Dec 8;118(24):6258-68
pubmed: 21998215
Stem Cell Reports. 2020 Aug 11;15(2):529-545
pubmed: 32679066
PeerJ. 2020 Feb 25;8:e8595
pubmed: 32140302
Vox Sang. 2007 Nov;93(4):331-40
pubmed: 18070278
Br J Clin Pharmacol. 2013 Jun;75(6):1406-21
pubmed: 23216370
BMC Res Notes. 2018 Oct 10;11(1):708
pubmed: 30309394
Front Oncol. 2020 Apr 28;10:658
pubmed: 32411609
Genomics. 2007 Nov;90(5):574-82
pubmed: 17764892
Biochem Biophys Res Commun. 2007 Nov 16;363(2):329-35
pubmed: 17880923
Nat Med. 2021 Feb;27(2):270-278
pubmed: 33335323
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Physiol Genomics. 2016 Mar;48(3):202-9
pubmed: 26757800
Nature. 2020 Oct;586(7830):578-582
pubmed: 32731258
Clin Sports Med. 2009 Oct;28(4):533-43, v-vi
pubmed: 19819400
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Cell Rep. 2019 Jun 11;27(11):3228-3240.e7
pubmed: 31189107
Clin Med (Lond). 2012 Jun;12(3):257-60
pubmed: 22783779
Genes (Basel). 2019 Mar 21;10(3):
pubmed: 30901981
Clin Lab Med. 2008 Mar;28(1):127-43, viii
pubmed: 18194723
Drug Test Anal. 2021 Jul 3;:
pubmed: 34216436
Genes (Basel). 2020 Jul 06;11(7):
pubmed: 32640671
BMC Genomics. 2020 Jun 29;21(1):446
pubmed: 32600246
Genes (Basel). 2019 Jun 08;10(6):
pubmed: 31181711
Expert Rev Hematol. 2018 Mar;11(3):169-184
pubmed: 29400094
Virology. 2002 Apr 10;295(2):284-8
pubmed: 12033787
Trends Analyt Chem. 2011 Jun;30(6):887-898
pubmed: 32287536
Discov Med. 2015 Jan;19(102):49-57
pubmed: 25636961
Genes Dev. 2008 Feb 15;22(4):463-75
pubmed: 18258751
Gene Ther. 2010 Aug;17(8):1022-32
pubmed: 20463760
Nat Med. 2021 Feb;27(2):279-288
pubmed: 33335322
J Lab Clin Med. 2006 Mar;147(3):126-32
pubmed: 16503242
Exp Hematol. 2020 Aug;88:28-41
pubmed: 32629063
Hum Genet. 2018 Feb;137(2):151-160
pubmed: 29362874
Drug Test Anal. 2021 May 7;:
pubmed: 33961347
IUBMB Life. 2020 Jan;72(1):106-118
pubmed: 31652397
BMC Res Notes. 2019 Mar 13;12(1):133
pubmed: 30867032
Med Sci Sports Exerc. 2000 Jul;32(7):1238-43
pubmed: 10912888
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Mol Cell Biol. 2002 Jun;22(12):4158-66
pubmed: 12024029
BMC Genomics. 2017 Nov 14;18(Suppl 8):817
pubmed: 29143667
PLoS One. 2011;6(10):e26068
pubmed: 22022510
Cell Rep. 2016 Aug 30;16(9):2373-86
pubmed: 27545894
J Gene Med. 2019 Jul;21(7):e3108
pubmed: 31246328
BMC Med. 2012 Apr 19;10:39
pubmed: 22515324
Drug Test Anal. 2012 Nov;4(11):859-69
pubmed: 22508654
J Clin Invest. 2020 Apr 1;130(4):1843-1849
pubmed: 31895700
PPAR Res. 2009;2009:476217
pubmed: 19884982
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Anal Bioanal Chem. 2018 Apr;410(10):2569-2583
pubmed: 29504082
Nat Biotechnol. 2017 Apr 11;35(4):310-312
pubmed: 28398329

Auteurs

Takehito Sugasawa (T)

Laboratory of Clinical Examination/Sports Medicine, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.

Takuro Nakano (T)

Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.

Shin-Ichiro Fujita (SI)

Laboratory of Clinical Examination/Sports Medicine, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.

Yuki Matsumoto (Y)

Research and Development Section, Anicom Specialty Medical Institute Inc., 2-6-3 Chojamachi 5F, Yokohama 231-0033, Japan.

Genki Ishihara (G)

Research and Development Section, Anicom Specialty Medical Institute Inc., 2-6-3 Chojamachi 5F, Yokohama 231-0033, Japan.

Kai Aoki (K)

Laboratory of Clinical Examination/Sports Medicine, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.
Japan Society for the Promotion of Science, Kojimachi Business Center Building, Kojimachi, Chiyoda-ku, Tokyo 102-0083, Japan.

Koki Yanazawa (K)

Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.

Seiko Ono (S)

Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.

Shinsuke Tamai (S)

Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.

Lev Manevich (L)

Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.
Department of Experimental Pathology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.

Haruna Ueda (H)

Analyst-Accenture Technology, Intelligent Platform Services, Accenture Japan Ltd., Akasaka Intercity AIR, 1-8-1 Akasaka, Minato-ku, Tokyo 107-8672, Japan.

Noriyo Ishibashi (N)

Tsukuba i-Laboratory LLP, 2-1-17 Amakubo, Tsukuba 305-0005, Japan.

Kenshirou Tamai (K)

Tsukuba i-Laboratory LLP, 2-1-17 Amakubo, Tsukuba 305-0005, Japan.

Yasuharu Kanki (Y)

Laboratory of Clinical Examination/Sports Medicine, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.

Yasuko Yoshida (Y)

Laboratory of Clinical Examination/Sports Medicine, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.
Department of Medical Technology, Faculty of Health Sciences, Tsukuba International University, 6-20-1 Manabe, Tsuchiura 300-0051, Japan.

Koichi Watanabe (K)

Faculty of Health and Sport Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8574, Japan.

Tohru Takemasa (T)

Faculty of Health and Sport Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8574, Japan.

Yasushi Kawakami (Y)

Laboratory of Clinical Examination/Sports Medicine, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.

Kazuhiro Takekoshi (K)

Laboratory of Clinical Examination/Sports Medicine, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH